Examples of using See sections in English and their translations into German
{-}
-
Medicine
-
Financial
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
See sections 4.5 and 5.2.
Breast feeding see sections 4.6 and 5.3.
See Sections 6.6.1 and 6.6.2.
No data are available see sections 5.1 and 5.2.
See Sections 4.3.2 for share issuers and 4.4.
Tracking is configured(see sections 11.3 and 11.4) 5.
Dose-related peripheral neuropathy occurred in monotherapy trials with Zerit see sections 4.2 and 4.4.
To change impedance, see sections on impedance Selection and Connections.
The campaign of Hunain(January 630, see sections 22.1 to10);
See sections 4.2 and 4.3 the potential risks and benefits of anagrelide therapy in a patient with mild impairment of hepatic function should be assessed before treatment is commenced.
The campaign of Uhud(March 625, see sections 16.1 to 22);
Safety and pharmacodynamic results in these patients are consistent with results observed inpatients 5 to 57 years old see sections 4.8.
The campaign to Ta'if(February 630, see sections 22.15 to 18); and.
Since the brinzolamide component of SIMBRINZA and its metabolite are excreted predominantly by the kidney,SIMBRINZA is contraindicated in such patients see sections 4.3.
You can clean this filter by descaling the kettle, see sections‘Descaling the kettle' below.
Special functions can be programmed andretrieved with ARTROMOT -S3 Comfort devices see sections 5.4 and 5.5.
Caution should be exercised when prescribing or uptitrating ranolazine to patients in whom an increased exposure is expected:•Concomitant administration of moderate CYP3A4 inhibitors(see sections 4.2 and 4.5).• Concomitant administration of P-gp inhibitors(see sections 4.2 and 4.5).• Mild hepatic impairment(see sections 4.2 and 5.2).• Mild to moderate renal impairment(creatinine clearance 30- 80 ml/ min)(see sections 4.2, 4.8, and 5.2).• Elderly(see sections 4.2, 4.8, and 5.2).• Patients with low weight(≤ 60 kg)(see sections 4.2, 4.8, and 5.2).• Patients with moderate to severe CHF(NYHA Class III- IV) see sections 4.2 and 5.2.
For multiple-part postings or diffs(files of changes), see Sections 2.4 and 2.5.
Always make sure nylon string head or blade have been assembled correctly(see sections NYLON STRING HEAD and BLADE ASSEMBLY) and blade fastener is tightened.
Data on a third dose(booster)administered 6 months after the first dose are limited see sections 4.8 and 5.1.
No data are available to make dose recommendations see sections 4.2 and 4.4.
Special rules apply where Public Officials are involved see sections 9 and 10.
Limited information is available in this population see sections 4.4 and 5.2.
During commissioning, the filter must be flushed and bled see Sections 6.8.1 to 6.8.3.
There are no data in patients with severe renal impairment see sections 4.2 and 4.4.
The ECB requirements in terms of timeliness anddetail are identical to the requirements for other short-term statistics see Sections 4.5 and 4.6.
Use of tolvaptan in combination with other options may increase the risk ofoverly rapid correction of serum sodium see sections 4.4 and 4.5.
In rare cases severe liver impairment has been described, including cholestasis, icterus,hepatic necrosis and hepatic failure with fatal outcome see sections 4.8 and 4.5.
Concomitant administration of calcium folinate with 5-fluorouracil hasbeen shown to enhance the efficacy and toxicity of 5-fluorouracil see sections 4.2, 4.4 and 4.8.
For permanent invalidity or death resulting from an accident at work, you will be paid an invalidity pension oryour dependants will receive a survivor's pension see Sections 2.4 and 2.5.2.